The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


AERINAZE

2.5/120 Milligram Tablets

Merck Sharp & Dohme LtdEU/1/07/399/001-006

Main Information

Trade NameAERINAZE
Active SubstancesDESLORATIDINE
PSEUDOEPHEDRINE SULFATE
Strength2.5/120 Milligram
Dosage FormTablets
Licence HolderMerck Sharp & Dohme Ltd
Licence NumberEU/1/07/399/001-006

Group Information

ATC CodeR01BA52 pseudoephedrine, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued30/07/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back